| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.70B | -5.8% |
| Cost of Revenue | $2.62B | -5.6% |
| R&D Expense | $133.8M | -21.0% |
| SG&A Expense | $356.2M | -9.2% |
| Operating Income | $237.5M | +59.1% |
| Pre-tax Income | $123.3M | +1141.6% |
| Income Tax | $92.0M | +165.6% |
| Net Income | $31.3M | -75.6% |
| EPS (Basic) | $0.21 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $573.0M | -3.5% |
| Accounts Receivable | $657.4M | -0.4% |
| Inventory | $617.8M | +0.5% |
| Current Assets | $1.99B | -1.6% |
| Total Assets | $6.75B | -5.5% |
| Current Liabilities | $775.1M | +9.0% |
| Long-term Debt | $2.85B | -11.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $621.5M | +12.7% |
| Investing Cash Flow | -$95.8M | -400.1% |
| Financing Cash Flow | -$550.6M | -24.3% |
| -75.3% |
| EPS (Diluted) | $0.21 | -75.3% |
| Total Liabilities |
| $3.97B |
| -6.7% |
| Stockholders' Equity | $2.79B | -3.6% |